South Africa in the news:
- BioNTech Sees Potential to Supply 3 Billion Doses in 2022: BioNTech SE could have capacity to make 3 billion doses of Covid-19 vaccine with U.S. partner Pfizer Inc. next year, the German company’s chief executive officer said, making their pioneering shot far …: “South Africa” – BingNews
- Trial and error: How scientists studied drugs touted to treat COVID-19: Eyewitness News looks back on one of the drugs that was famously touted – even by people in influence – as part of a treatment regimen for COVID-19.: “South Africa” – BingNews
- EXPLAINER-Activists, drug groups split over suspending COVID-19 shot patents: A World Trade Organization (WTO) council is meeting this week to discuss a proposal by India and South Africa that COVID-19 vaccine patents be suspended to speed up technology transfers to …: “South Africa” – BingNews
- Genetic Modification Therapies Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030: The global Genetic Modification Therapies market is expected to exceed more than US$ 3.5 Billion by 2024 at a CAGR of 34% …: “South Africa” – BingNews
- A weary world looks back — and forward: No one has been untouched. Not the Michigan woman who awakened one morning, her relative = dead by her side. Not the domestic worker in Mozambique, her livelihood threatened by the virus. Not the …: “South Africa” – BingNews